In 1998 was created Deutsche Venture Capital, which is appeared as VC. The company was established in Europe in Germany. The main department of described VC is located in the Mu00fcnchen.
The overall number of key employees were 1.
The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Germany. Among the various public portfolio startups of the fund, we may underline Onix Microsystems, End2End Holdings, 4SC We can highlight the next thriving fund investment areas, such as Medical, Therapeutics.
Comparing to the other companies, this Deutsche Venture Capital performs on 19 percentage points more the average number of lead investments. The typical startup value when the investment from Deutsche Venture Capital is 10-50 millions dollars. The top activity for fund was in 2005. The fund is constantly included in less than 2 deals per year. The real fund results show that this VC is 9 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2013.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Deutsche Venture Capital, startups are often financed by 3i Group, Zimmer Lucas Partners, Urs Ehrismann. The meaningful sponsors for the fund in investment in the same round are 3i Group, Techno Venture Management, Sofinnova Partners. In the next rounds fund is usually obtained by Hewlett-Packard, DFJ, DB Capital Ventures.
Company | Industry | Round | Round Size | Date | Investors | Location |
BigMachines | 29M | 19 Mar 2001 | United States, Deerfield | |||
Onix Microsystems | 95M | 06 Aug 2001 | United States, Tucson | |||
Develogen AG | 47M | 18 Apr 2001 | Germany, Göttingen | |||
Dolthera GmbH | 17M | 12 Aug 2005 | Germany, Planegg | |||
9M | 21 Apr 2021 | |||||
Panoratio | 732K | 21 Apr 2021 | Germany, Munich | |||
Roche Glycart | 13M | 21 Apr 2021 | Switzerland, Schlieren | |||
14M | 21 Apr 2021 | |||||
12M | 21 Apr 2021 |
By posting comments on our website you confirm and acknowledge that:
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.